Cannabis Cannabis Community College unveils new 5-course bundle New online curriculum is intended to provide leverage to job seekers in the industry Rowan DunneSeptember 7, 2022
Psychedelics Xtalks to host upcoming webinar on psychedelic know-how Free virtual conference will discuss unique requisites of psychedelic clinical development Rowan DunneSeptember 7, 2022
Cannabis The lazy stoner myth debunked: University of Cambridge New research shows that there is no scientific basis for pervading stereotype Rowan DunneSeptember 7, 2022
Sleep Amazfit unveils new sleep tracking smartwatches New devices will utilize improved sleep monitoring features Rowan DunneSeptember 6, 2022
Research Psychedelic use rising as the market expands: MicroSmallCap New report outlines statistics and recent accomplishments made in the field Rowan DunneSeptember 6, 2022
Canada Field Trip facilitates beneficial psychedelic-assisted therapy for cancer patient Patient participated in ketamine and psilocybin sessions through the Special Access Program from Health Canada Rowan DunneSeptember 2, 2022
Canada Filament administers psilocybin to 14 participants in Health Canada sanctioned clinical trial Clinical trial will be conducted as part of the ATMA Journey Centre's psychedelic-assisted therapist training program Rowan DunneSeptember 1, 2022
Psychedelics Heroic Hearts collaborates with Maya to streamline psychedelic data for veterans Influencing policies, cataloguing proof of efficacy and assisting veterans integration processes will be ideal outcomes from partnership Rowan DunneSeptember 1, 2022
International PharmAla Biotech to provide University of Sydney with LaNeo MDMA for clinical studies Organization to supply GMP product for second major clinical trial down under this month Rowan DunneAugust 31, 2022
Canada Mindset Pharma discovers 3 novel next-gen psychedelic compounds Discovery of new drugs follows company decision to extend research outside of tryptamine class, i.e. psilocybin and DMT Rowan DunneAugust 31, 2022